12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's pre-market session, health care stocks showed significant movement. Sunshine Biopharma, CASI Pharmaceuticals, and Regenxbio were among the top gainers, with increases of 55.9%, 47.68%, and 37.17% respectively. On the downside, Lipella Pharmaceuticals, BIMI Intl Medical, and Quoin Pharmaceuticals led the losers, with declines of 32.0%, 31.16%, and 30.01% respectively. The movements reflect varying market capitalizations and recent earnings reports for some companies.
March 05, 2024 | 1:09 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BIMI Intl Medical's stock fell 31.16% to $2.32, with a market cap of $32.4 million.
The decline in BIMI Intl Medical's stock price likely reflects investor concerns or unfavorable news.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Lipella Pharmaceuticals' stock decreased by 32.0% to $0.7, with a market value of $4.3 million.
Lipella Pharmaceuticals' significant pre-market drop suggests negative investor sentiment or reactions to recent developments.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Quoin Pharmaceuticals' shares decreased by 30.01% to $2.03, with a market value of $2.0 million.
Quoin Pharmaceuticals' pre-market decline indicates potential investor disappointment or negative developments.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
CASI Pharmaceuticals' shares rose 47.68% to $7.51, with a market cap of $100.0 million.
CASI Pharmaceuticals' significant pre-market gain suggests strong investor confidence or favorable news impacting the stock.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Regenxbio's stock increased by 37.17% to $29.3, with a market value of $1.3 billion.
The substantial rise in Regenxbio's stock price could be attributed to positive market reactions to company performance or news.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Sunshine Biopharma's stock surged 55.9% in pre-market trading, with a market value of $3.8 million.
The significant pre-market surge in Sunshine Biopharma's stock likely reflects positive investor sentiment or reactions to recent company developments.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90